Aggressiveness of end-of-life cancer care: what happens in clinical practice?

[1] Adelson K(2017)Standardized criteria for palliative care consultation on a solid tumor oncology service reduces downstream health care use Journal of Oncology Practice 13 E431-EE40

[2] Paris J(2018)NCCN frameworks for resource stratification of NCCN guidelines: adult cancer pain and palliative care J Natl Compr Cancer Netw 16 628-631

[3] Horton JR(2003)Identifying potential indicators of the quality of end-of-life cancer care from administrative data J Clin Oncol 21 1133-1138

[4] Hernandez-Tellez L(2005)Evaluating claims-based indicators of the intensity of end-of-life cancer care Int J Qual Health Care 17 505-509

[5] Ricks D(1982)Toxicity and response criteria of the Eastern Cooperative Oncology Group American Journal of Clinical Oncology-Cancer Clinical Trials 5 649-655

[6] Morrison RS(2004)Trends in the aggressiveness of cancer care near the end of life J Clin Oncol 22 315-321

[7] Smith CB(2019)Systemic anticancer therapy in the last 30 days of life: retrospective audit from an Australian regional Cancer Centre J Oncol Pharm Pract 25 599-606

[8] Swarm RA(2017)Therapeutic aggressiveness and liquid oncology Cuadernos De Bioetica 28 71-81

[9] Dans M(2019)Multicentre analysis of intensity of care at the end-of-life in patients with advanced cancer, combining health administrative data with hospital records: variations in practice call for routine quality evaluation Bmc Palliative Care 18 35-24

[10] Earle CC(2016)Chemotherapy near the end of life; assessment of the clinical practise in onco-hematological in adult patients Farm Hosp 40 14-491

[1] Adelson K(2017)Standardized criteria for palliative care consultation on a solid tumor oncology service reduces downstream health care use Journal of Oncology Practice 13 E431-EE40

[2] Paris J(2018)NCCN frameworks for resource stratification of NCCN guidelines: adult cancer pain and palliative care J Natl Compr Cancer Netw 16 628-631

[3] Horton JR(2003)Identifying potential indicators of the quality of end-of-life cancer care from administrative data J Clin Oncol 21 1133-1138

[4] Hernandez-Tellez L(2005)Evaluating claims-based indicators of the intensity of end-of-life cancer care Int J Qual Health Care 17 505-509

[5] Ricks D(1982)Toxicity and response criteria of the Eastern Cooperative Oncology Group American Journal of Clinical Oncology-Cancer Clinical Trials 5 649-655

[6] Morrison RS(2004)Trends in the aggressiveness of cancer care near the end of life J Clin Oncol 22 315-321

[7] Smith CB(2019)Systemic anticancer therapy in the last 30 days of life: retrospective audit from an Australian regional Cancer Centre J Oncol Pharm Pract 25 599-606

[8] Swarm RA(2017)Therapeutic aggressiveness and liquid oncology Cuadernos De Bioetica 28 71-81

[9] Dans M(2019)Multicentre analysis of intensity of care at the end-of-life in patients with advanced cancer, combining health administrative data with hospital records: variations in practice call for routine quality evaluation Bmc Palliative Care 18 35-24

[10] Earle CC(2016)Chemotherapy near the end of life; assessment of the clinical practise in onco-hematological in adult patients Farm Hosp 40 14-491